BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16415907)

  • 1. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
    Hoi PM; Hiley CR
    Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
    Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
    Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
    Sudhahar V; Shaw S; Imig JD
    Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.
    AlSuleimani YM; Hiley CR
    Eur J Pharmacol; 2013 Feb; 702(1-3):1-11. PubMed ID: 23340219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.
    Harris D; McCulloch AI; Kendall DA; Randall MD
    J Physiol; 2002 Mar; 539(Pt 3):893-902. PubMed ID: 11897858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
    McCulloch AI; Randall MD
    Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
    Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
    Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension.
    Hopps JJ; Dunn WR; Randall MD
    Eur J Pharmacol; 2012 Jun; 684(1-3):102-7. PubMed ID: 22465182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed.
    Ralevic V
    Br J Pharmacol; 2002 Sep; 137(1):19-28. PubMed ID: 12183327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
    Hiley CR; Hoi PM
    Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
    Mendizábal VE; Orliac ML; Adler-Graschinsky E
    Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.
    McCulloch AI; Bottrill FE; Randall MD; Hiley CR
    Br J Pharmacol; 1997 Apr; 120(8):1431-8. PubMed ID: 9113362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.